Similarly, we found that E2F1 mRNA expression was increased in breast cancer cells MDA-MB-231, and MCF-7 (Fig. 4f) and up-regulated in the miR-185-3p inhibitor transfection and enhanced LINC00511 plasmid transfection (Fig. 4g). The gene discussed is E2F1; the disease is breast carcinoma.